Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 21, 2005; 11(39): 6182-6187
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6182
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6182
Table 1 Comparison of variables between cases and controls
Variable | Cases n = 97 | Controls n = 190 | P1 | ||||||||
Mean | SD | Median | Min | Max | Mean | SD | Median | Min | Max | ||
Age (yr) | 52.1 | 12.1 | 51.0 | 19.0 | 85.0 | 50.5 | 11.7 | 50 | 18.0 | 85 | 0.25 |
BMI (kg/m2) | 28.2 | 5.5 | 27.7 | 18.6 | 54.9 | 27 | 3.9 | 26.9 | 19.0 | 40.1 | 0.12 |
Leptin (ng/mL) | 18.2 | 44.7 | 10.2 | 1.9 | 431.0 | 11 | 6.5 | 9.5 | 1.3 | 40.7 | 0.11 |
Insulin (μU/mL) | 11.1 | 7.4 | 9.1 | 1.8 | 35.7 | 9.4 | 6.3 | 7.6 | 2.0 | 43.7 | 0.07 |
T-chol (mmol/L) | 5.43 | 1.09 | 5.46 | 2.48 | 8.38 | 5.38 | 1.03 | 5.4 3. | 36 | 9.44 | 0.95 |
LDL (mmol/L) | 3.44 | 0.85 | 3.36 | 1.11 | 5.61 | 3.49 | 0.85 | 3.41 | 1.60 | 6.13 | 0.73 |
HDL (mmol/L) | 1.19 | 0.36 | 1.14 | 0.47 | 2.72 | 1.22 | 0.36 | 1.14 | 0.52 | 2.56 | 0.42 |
NHDL (mmol/L) | 4.27 | 1.03 | 4.34 | 1.78 | 7.34 | 4.27 | 0.98 | 4.24 | 2.4 | 8.53 | 0.90 |
TGC (mmol/L) | 1.89 | 1.15 | 1.7 | 0.43 | 6.78 | 1.71 | 0.96 | 1.46 | 0.06 | 7.38 | 0.18 |
HOMA-IR | 2.9 | 2.2 | 2.3 | 0.4 | 11.7 | 2.4 | 1.8 | 1.8 | 0.4 | 13.2 | 0.04 |
Table 2 Comparison of variables between cases and controls, stratified by BMI
Variable | BMI <30 | P1 | BMI ≥30 | P1 | ||||||
Cases n = 72 | Controls n = 153 | Cases n = 25 | Controls n = 37 | |||||||
No | % | No | % | No | % | No | % | |||
Gender (male) | 42 | 58.3 | 89 | 58.2 | 1.0 | 13 | 52.0 | 22 | 59.5 | 0.61 |
Age >50 yr | 38 | 52.8 | 69 | 45.1 | 0.32 | 13 | 52.0 | 21 | 56.8 | 0.80 |
Leptin ≥9.78 ng/mL | 37 | 51.4 | 61 | 39.9 | 0.11 | 16 | 64.0 | 30 | 81.1 | 0.15 |
Leptin | 0.042 | 0.252 | ||||||||
Tercile1<7.67 ng/mL | 22 | 30.6 | 64 | 41.8 | 5 | 20.0 | 4 | 10.8 | ||
Tercile27.62.4 ng/mL | 25 | 34.7 | 54 | 35 | 3 7 | 28.0 | 9 | 24.3 | ||
Tercile3>12.4 ng/mL | 25 | 34.7 | 35 | 22.9 | 13 | 52.0 | 24 | 64.9 | ||
Insulin≥20μU/mL | 9 | 12.5 | 0 | 0 | <0.0001 | 4 | 16.0 | 12 | 32.4 | 0.24 |
HOMA-IR (>2.5) | 29 | 40.3 | 42 | 27.5 | 0.07 | 15 | 60 | 24 | 64.9 | 0.79 |
T-chol≥6.21 mmol/L | 19 | 26.4 | 45 | 29.4 | 0.75 | 6 | 24.0 | 6 | 16.2 | 0.52 |
LDL≥4.14 mmol/L3 | 19 | 27.1 | 40 | 26.7 | 1.0 | 5 | 21.7 | 7 | 18.9 | 1 |
HDL<1.03 mmol/L | 27 | 37.5 | 50 | 32.7 | 0.55 | 8 | 32.0 | 13 | 35.1 | 1 |
NHDL ≥4.91 mmol/L | 20 | 27.8 | 43 | 28.1 | 1.0 | 5 | 20.0 | 7 | 18.9 | 1 |
TGC ≥1.70 mmol/L | 32 | 44.4 | 62 | 40.5 | 0.66 | 17 | 68.0 | 14 | 37.8 | 0.04 |
Table 3 Univariated analysis of conditional logistic regression, stratified by BMI
Variable | BMI <30 | BMI ≥30 | ||||
OR | 95%CI | P | OR | 95%CI | P | |
Age (yr) | 1.20 | 0.97-1.49 | 0.09 | 0.93 | 0.68-1.26 | 0.62 |
Leptin (ng/mL) | 1.06 | 0.99-1.13 | 0.09 | 0.91 | 0.81-1.03 | 0.15 |
Insulin (μU/mL) | 1.09 | 1.02-1.16 | 0.01 | 0.94 | 0.86-1.03 | 0.17 |
HOMA-IR | 1.33 | 1.06-1.68 | 0.02 | 0.85 | 0.61-1.17 | 0.32 |
T-chol (mmol/L) | 1.0 | 0.99-1.00 | 0.32 | 1.02 | 0.99-1.05 | 0.27 |
LDL (mmol/L) | 1.0 | 0.99-1.01 | 0.51 | 1.01 | 0.98-1.05 | 0.39 |
HDL (mmol/L) | 0.99 | 0.97-1.01 | 0.44 | 1.02 | 0.95-1.09 | 0.66 |
NHDL (mmol/L) | 1.0 | 0.99-1.01 | 0.44 | 1.02 | 0.99-1.05 | 0.30 |
TGC (mmol/L) | 1.0 | 1.0-1.0 | 0.86 | 1.0 | 1.0-1.01 | 0.3 |
Leptin ≥9.78 ng/mL | 2.25 | 1.08-4.69 | 0.03 | 0.12 | 0.01-1.0 | 0.05 |
Leptin terciles (ng/mL) | 1.67 | 1.03-2.69 | 0.04 | 0.14 | 0.02-0.98 | 0.05 |
Insulin ≥20 μU/mL Non | convergence | 0.47 | 0.12-1.88 | 0.29 | ||
HOMA-IR >2.5 | 1.46 | 0.75-2.83 | 0.27 | 0.44 | 0.11-1.84 | 0.26 |
T-chol ≥6.21 mmol/L | 0.86 | 0.42-1.74 | 0.67 | 3.88 | 0.38-39.5 | 0.25 |
LDL ≥4.14 mmol/L | 1.06 | 0.55-2.04 | 0.87 | 1.50 | 0.36-630 | 0.58 |
HDL <1.03 mmol/L | 1.26 | 0.66-2.41 | 0.49 | Non convergence | ||
NHDL ≥4.91mmol/L | 1.07 | 0.54-2.13 | 0.84 | 0.78 | 0.07-8.88 | 0.84 |
TGC ≥1.7 mmol/L | 1.09 | 0.60-1.99 | 0.77 | 3.03 | 0.76-12.1 | 0.12 |
Table 4 Multivariated analysis of conditional logistic regression, stratified by BMI
Variables | BMI <30 | BMI ≥30 | ||||
OR | 95%CI | P | OR | 95%CI | P | |
HOMA-IR | 1.31 | 1.04-1.66 | 0.02 | No model founded | ||
Leptin ≥9.78 ng/mL | 2.1 | 1 0.99-4.53 | 0.05 |
- Citation: Méndez-Sánchez N, Bermejo-Martínez LB, Viñals Y, Chavez-Tapia NC, Graff IV, Ponciano-Rodríguez G, Ramos MH, Uribe M. Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects. World J Gastroenterol 2005; 11(39): 6182-6187
- URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6182.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i39.6182